Nutritional Supplementation in Geriatric Hip Fractures

Last updated: April 24, 2025
Sponsor: NYU Langone Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoporosis

Treatment

XR Carbohydrate Loading Supplement

XR™ Recovery Supplement

Clinical Study ID

NCT06773000
24-00895
  • Ages > 65
  • All Genders

Study Summary

This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is:

  • Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Male or female, aged 65 years or older.

  2. Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, orsubtrochanteric) requiring surgical intervention.

  3. Able to provide informed consent.

  4. Expected to survive at least 6 months after surgery, with no terminal illness.

Exclusion

Exclusion Criteria:

  1. Pre-existing conditions that significantly impair mobility prior to injury.

  2. Severe renal or liver impairment.

  3. Active treatment with investigational drugs or participation in another clinicaltrial within the last 30 days.

  4. Inability to tolerate oral nutritional supplementation due to gastrointestinaldisorders.

  5. Allergies to any components of the nutritional supplement being tested.

Study Design

Total Participants: 118
Treatment Group(s): 2
Primary Treatment: XR Carbohydrate Loading Supplement
Phase:
Study Start date:
January 16, 2025
Estimated Completion Date:
June 30, 2027

Connect with a study center

  • NYU Langone Health

    New York, New York 10016
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.